SITC’s Guide to Managing Immunotherapy Toxicity
Marc Ernstoff (Redaktør) Igor Puzanov, MD, MSCI, FACP (Redaktør) Caroline Robert, MD, PhD (Redaktør) Adi M. Diab, MD (Redaktør) Peter M. Hersey, MD, PhD (Redaktør)
SITC's Guide to Managing Immunotherapy Toxicity is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with Anti-CTLA4 agents, Anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. Les mer
With chapters written by world recognized oncology leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care.
Key Features:
Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy
Provides numerous tables that condense and highlight pertinent information for quick reference
Describes the various clinical presentations and toxic reactions caused by immunotherapy
Includes access to the fully searchable downloadable eBook
Detaljer
- Forlag
- Springer Publishing Co Inc
- Innbinding
- Paperback
- Språk
- Engelsk
- Sider
- 274
- ISBN
- 9780826172143
- Utgivelsesår
- 2019
- Format
- 20 x 13 cm